| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |